Delcath Systems (DCTH) is on the Move, Here's Why the Trend Could be Sustainable
Delcath Systems, Inc. (DCTH) is a Great Momentum Stock: Should You Buy?
Wall Street Analysts Think Delcath Systems (DCTH) Could Surge 27.7%: Read This Before Placing a Bet
BTIG Reiterates Buy on Delcath Systems, Maintains $25 Price Target
Delcath Systems to Be Featured on "Health Uncensored with Dr. Drew" in Segment Highlighting Advances in Liver-Directed Cancer Treatment
HC Wainwright & Co. Maintains Buy on Delcath Systems, Raises Price Target to $36
Delcath Systems Inc (DCTH) (Q3 2026) Earnings Call Highlights: Record Revenue, Raised Guidance ...
Delcath (DCTH) Q3 2026 Earnings Call Transcript
Delcath Systems Reports 70% Revenue Growth in Q3 2026 and Raises Full-Year Guidance to $115 Million–$117 Million
Delcath Systems Q3 Earnings Call Highlights
Delcath Systems (NASDAQ:DCTH) Stock Jumps Premarket on Strong Q3 2026 Earnings Beat and Above-Consensus Guidance
Delcath Systems, Inc. (DCTH) Q3 Earnings and Revenues Top Estimates
Delcath Systems Reports Third Quarter 2026 Results and Business Highlights
BTIG Maintains Buy on Delcath Systems, Raises Price Target to $25
Delcath Systems, Inc. (DCTH) Q3 2026 Earnings Call Transcript
Delcath Systems Q3 2026 Earnings Call Transcript
Delcath Systems Raises FY2026 Sales Guidance from $104.000M-$108.000M to $115.000M-$117.000M vs $106.507M Est
Delcath Systems Q3 EPS $0.17 Beats $(0.09) Estimate, Sales $35.102M Beat $26.027M Estimate
Delcath Systems: Intriguingly Poised Ahead Of Q3 Earnings
Delcath Systems to Participate in Upcoming Investor Conferences
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.